Student Loan Forgiveness

Students struggling to pay off college loans might find this advertisement’s promise of reducing payments by 90 percent quite attractive. But before you send any information, you should be wary…

Tomo ‘Post-Alcohol Recovery’ Supplement

TINA.org breaks down the legal issues of marketing a “hangover supplement.”

CalmOptics

Don’t let the claims about these blue-light blocking glasses blind you to the facts.

7 Marketers That Get Coal in Their 2019 Holiday Stocking

TINA.org’s annual list includes a pillow maker, a televangelist and a for-profit college.

DeVry University’s Advertised Employment and Income Rates

Coleman University

Brightwood College

All Star Driver Education

Driving school advertises access to online course materials as available 24/7. But it’s actually more like 20/7.

Le Cordon Bleu

Savannah Law School

Doctoral Degrees at Capella University

What Social Media Can Teach Us about Consumer Protection

Arm consumers with X-ray vision to protect them from scams circulating on Facebook.

Walden University’s Doctoral Degrees

DeVry University to Pay $100M to Settle FTC Charges

Agency alleged for-profit institution touted deceptive job placement figures.

Vemma Reaches Settlement Agreement in FTC Pyramid Case

Company struggled under court-mandated customer-focused business structure.

Accrediting Council for Independent Colleges and Schools

Federal education officials move to revoke for-profit college accreditor’s recognition.

Vemma Frenzy Ends: Judge Limits Vemma’s Operations

Court concludes Vemma likely operating a pyramid scheme.

Energy Drink Company Shut Down Amidst Pyramid Scheme Allegations

Ad Watchdog’s Investigation Spurs FTC Action MADISON, CONN. August 26, 2015 — Vemma Nutrition, an Arizona-based dietary supplement and energy drink company, was quietly shut down by the Federal Trade…

Not Very Presidential, Guys

Allegations of misleading advertising and questionable products follow four GOP candidates into tonight’s debate.

A Year after Signaling E-Cig Action, FDA Issues First Warning Letters

Sites warned about misleading claims.